GRAYROBINSON PA

GRAYROBINSON PA filed a Q2 termination report for OMEROS CORPORATION on July 18, 2025, reporting no lobbying activity.

Lobbying for OMEROS CORPORATION · Biopharmaceutical company focused on small-molecule and protein therapeutics.

Filing · LD-2 quarterly report Q2 terminationNo activity

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Washington

Representation ended

Apr 1, 2025

The registrant reported terminating its work for this client.

Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.